#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant oligodendroglioma Spinal muscular atrophy Hepatitis B Neuroendocrine tumour Prader-Willi syndrome Glycogen storage disease type II Fusarium infection Conjunctivitis allergic Mycobacterium abscessus infection Neuroblastoma Squamous cell carcinoma of the cervix Myeloid leukaemia Giant cell tumour of tendon sheath Synovial sarcoma metastatic Uterine leiomyosarcoma More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Basic Information Skin angiosarcoma – Basic Information Osteosarcoma metastatic Haemolytic uraemic syndrome – Diagnostics Cytokine release syndrome – Basic Information Hereditary neuropathic amyloidosis – Treatment Marfan’s syndrome – Trials in Disease IgA nephropathy – Life with Disease KBG syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clemastine Anthoxanthum Odoratum Amantadine Hydrochloride Monalizumab Olaparib ANTIMETABOLITES Valemetostat Tosilate Ucart20X22 L-SERINE HTL0022537 Nortriptyline Estradiol Hemihydrate Garadacimab Bms-986408 Morf-057 Pregabalin Cefixime Trihydrate INF904 Glycerol Risedronate Sodium More therapies…

    Learn about Your Condition

    Diabetic retinal oedema B-cell lymphoma refractory Diffuse large B-cell lymphoma Metabolic syndrome Constipation Chondrocalcinosis Pancreatic carcinoma stage IV Vulvovaginal candidiasis Chronic hepatitis C Retinal vein occlusion Graft infection Liposarcoma metastatic Agitation Hepatic angiosarcoma Ewing's sarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pauls Stradins Clinical University Hospital

Pauls Stradins Clinical University Hospital

Pilsonu Iela 13, Riga, 1002, Latvia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10

  • Study on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Choroidal neovascularisation
    • Diabetic retinal oedema
    • Diabetic retinopathy
    Investigated Drugs:
    • Aflibercept
    Latvia

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tanimilast
    Bulgaria Czechia Germany Hungary Italy Latvia +4

  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Czechia Estonia France Germany Hungary Italy +6

  • Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Estonia Finland +14

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Morf-057
    Austria Bulgaria Czechia Estonia France Germany +7

  • Study on REGN9933 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Apixaban
    • Enoxaparin Sodium
    • Regn9933
    Belgium Bulgaria Hungary Latvia Lithuania Poland

  • Study on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy

    Not recruiting

    3 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Azetukalner
    Bulgaria Czechia Germany Ireland Italy Latvia +3

  • Study on Tildacerfont to Reduce Glucocorticoid Use in Adults with Classic Congenital Adrenal Hyperplasia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Hydrocortisone
    • Prednisolone
    • Tildacerfont
    Denmark Estonia Germany Ireland Italy Latvia +6
Previous Page
1 … 10 11 12 13 14 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!